Although historically research has focused on transcription as the central governor of protein expression, protein translation is now increasingly being recognized as a major factor for determining protein levels within cells. The central nervous system relies on efficient updating of the protein landscape. Thus, coordinated regulation of mRNA localization, initiation, or termination of translation is essential for proper brain function. In particular, dendritic protein synthesis plays a key role in synaptic plasticity underlying learning and memory as well as cognitive processes. Increasing evidence suggests that impaired mRNA translation is a common feature found in numerous psychiatric disorders. In this review, we describe how malfunction of translation contributes to development of psychiatric diseases, including schizophrenia, major depression, bipolar disorder, and addiction.
AdaikkanCTahaEBarreraIDavidORosenblumK.2018. Calcium/calmodulin-dependent protein kinase II and eukaryotic elongation factor 2 kinase pathways mediate the antidepressant action of ketamine. Biol Psychiatry84:65–75.
2.
Aguilar-VallesAHajiNDe GregorioDMatta-CamachoEEslamizadeMJPopicJ, and others. 2018. Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E. Nat Commun9:2459.
3.
AmorimISKediaSKoulouliaSSimbrigerKGantoisIJafarnejadSM, and others. 2018. Loss of eIF4E phosphorylation engenders depression-like behaviors via selective mRNA translation. J Neurosci38:2118–33.
4.
AuerbachBDOsterweilEKBearMF. 2011. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature480:63–8.
5.
BahiADreyerJL. 2013. Striatal modulation of BDNF expression using microRNA124a-expressing lentiviral vectors impairs ethanol-induced conditioned-place preference and voluntary alcohol consumption. Eur J Neurosci38:2328–37.
6.
BaileyJMaDSzumlinskiKK. 2012. Rapamycin attenuates the expression of cocaine-induced place preference and behavioral sensitization. Addict Biol17:248–58.
7.
BarakSLiuFBen HamidaSYowellQVNeastaJKharaziaV, and others. 2013. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nat Neurosci16:1111–7.
8.
BastleRMOliverRJGardinerASPentkowskiNSBolognaniFAllanAM, and others. 2018. In silico identification and in vivo validation of miR-495 as a novel regulator of motivation for cocaine that targets multiple addiction-related networks in the nucleus accumbens. Mol Psychiatry23:434–43.
9.
BeckleyJTLaguesseSPhamluongKMorisotNWegnerSARonD.2016. The first alcohol drink triggers mTORC1-dependent synaptic plasticity in nucleus accumbens dopamine D1 receptor neurons. J Neurosci36:701–13.
10.
BellatoHMHajjGN. 2016. Translational control by eIF2α in neurons: beyond the stress response. Cytoskeleton (Hoboken) 73:551–65.
11.
Ben HamidaSLaguesseSMorisotNParkJHPhuamluongKBergerAL, and others. 2018. Mammalian target of rapamycin complex 1 and its downstream effector collapsin response mediator protein-2 drive reinstatement of alcohol reward seeking. Addict Biol. Epub Jul18.
12.
BerminghamRCarballedoALisieckaDFaganAMorrisDFaheyC, and others. 2012. Effect of genetic variant in BICC1 on functional and structural brain changes in depression. Neuropsychopharmacology37:2855–62.
13.
BieverABoubaker-VitreJCutandoLGracia-RubioICosta-MattioliMPuighermanalE, and others. 2016Repeated exposure to D-amphetamine decreases global protein synthesis and regulates the translation of a subset of mRNAs in the striatum. Front Mol Neurosci9:165.
14.
BieverAPuighermanalENishiADavidAPanciaticiCLonguevilleS, and others. 2015a. PKA-dependent phosphorylation of ribosomal protein S6 does not correlate with translation efficiency in striatonigral and striatopallidal medium-sized spiny neurons. J Neurosci35:4113–30.
15.
BieverAValjentEPuighermanalE.2015b. Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function. Front Mol Neurosci8:75.
16.
BrinegarAECooperTA. 2016. Roles for RNA-binding proteins in development and disease. Brain Res1647:1-8.
17.
BrowneGJFinnSGProudCG. 2004. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem279:12220–31.
18.
BryantCDYazdaniN.2016. RNA-binding proteins, neural development and the addictions. Genes Brain Behav15:169–86.
19.
BuffingtonSAHuangWCosta-MattioliM.2014. Translational control in synaptic plasticity and cognitive dysfunction. Annu Rev Neurosci37:17–38.
20.
ChenEJosephS.2015. Fragile X mental retardation protein: a paradigm for translational control by RNA-binding proteins. Biochimie114:147–54.
21.
ChenJLinMHrabovskyAPedrosaEDeanJJainS, and others. 2015. ZNF804A transcriptional networks in differentiating neurons derived from induced pluripotent stem cells of human origin. PLoS One10:e0124597.
22.
CuiYZhangXQCuiYXinWJJingJLiuXG. 2010. Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats. Neuroscience171:134–43.
23.
DagestadGKuipersSDMessaoudiEBramhamCR. 2006. Chronic fluoxetine induces region-specific changes in translation factor eIF4E and eEF2 activity in the rat brain. Eur J Neurosci23:2814–8.
24.
DarcqEWarnaultVPhamluongKBessererGMLiuFRonD.2015. MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption. Mol Psychiatry20:1219–31.
25.
DennisMDJeffersonLSKimballSR. 2012. Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis. J Biol Chem287:42890–9.
26.
DeverTEGreenR.2012. The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb Perspect Biol4:a013706.
27.
DiggleTASubkhankulovaTLilleyKSShikotraNWillisAERedpathNT. 2001. Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity. Biochem J353:621–6.
28.
DwivediY. 2016. Pathogenetic and therapeutic applications of microRNAs in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry64:341–8.
29.
DwyerJMMaldonado-AvilesJGLepackAEDiLeoneRJDumanRS. 2015. Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior. Proc Natl Acad Sci U S A112:6188–93.
30.
EnglishJAFanYFöckingMLopezLMHryniewieckaMWynneK, and others. 2015. Reduced protein synthesis in schizophrenia patient–derived olfactory cells. Transl Psychiatry5:e663.
31.
EulalioAHuntzingerEIzaurraldeE.2008. Getting to the root of miRNA-mediated gene silencing. Cell132:9–14.
32.
FanJLiBGeTZhangZLvJZhaoJ, and others. 2017. Berberine produces antidepressant-like effects in ovariectomized mice. Sci Rep7:1310.
33.
FangYQiuQZhangSSunLLiGXiaoS, and others. 2018. Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression. J Affect Disord227:745–51.
34.
FatemiSHFolsomTDThurasPD. 2017. Altered subcellular localization of fragile X mental retardation signaling partners and targets in superior frontal cortex of individuals with schizophrenia. Neuroreport28:1066–70.
35.
FatemiSHKneelandRELieschSBFolsomTD. 2010. Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizophr Res124:246–7.
36.
FlexnerJBFlexnerLBStellarE.1963. Memory in mice as affected by intracerebral puromycin. Science141:57–9.
37.
ForrestMPParnellEPenzesP.2018. Dendritic structural plasticity and neuropsychiatric disease. Nat Rev Neurosci19:215–34.
38.
FriesGRCarvalhoAFQuevedoJ.2018. The miRNome of bipolar disorder. J Affect Disord233:110–6.
39.
GandinVMasvidalLHuleaLGravelSPCargnelloMMcLaughlanS, and others. 2016. nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs. Genome Res26:636–48.
40.
GibbonsAUdawelaMDeanB.2018. Non-coding RNA as novel players in the pathophysiology of schizophrenia. Noncoding RNA4(2):E11.
HansonGCollerJ.2018. Codon optimality, bias and usage in translation and mRNA decay. Nat Rev Mol Cell Biol19:20–30.
45.
HarrisonPJ.2017. ZNF804A: insights from the first genome-wide significant schizophrenia gene. Biol Psychiatry82:6–7.
46.
HarrisonPJGeddesJRTunbridgeEM. 2018. The emerging neurobiology of bipolar disorder. Trends Neurosci41:18–30.
47.
HeYWangZJ. 2012. Let-7 microRNAs and opioid tolerance. Front Genet3:110.
48.
HeYZhouYXiQCuiHLuoTSongH, and others. 2012. Genetic variations in microRNA processing genes are associated with susceptibility in depression. DNA Cell Biol31:1499–506.
49.
HellenCUT. 2018. Translation termination and ribosome recycling in eukaryotes. Cold Spring Harb Perspect Biol10:a032656.
50.
HollanderJAImHIAmelioALKocerhaJBaliPLuQ, and others. 2010. Striatal microRNA controls cocaine intake through CREB signalling. Nature466:197–202.
51.
HoltCESchumanEM. 2013. The central dogma decentralized: new perspectives on RNA function and local translation in neurons. Neuron80:648–57.
52.
HuangWPlaczekANVianaDiPriscoGKhatiwadaSSidrauskiCKrnjevicK, and others. 2016. Translational control by eIF2α phosphorylation regulates vulnerability to the synaptic and behavioral effects of cocaine. eLife5:e12052.
53.
Ibarra-LecueIMollinedo-GajateIMeanaJJCalladoLFDiez-AlarciaRUriguenL.2018. Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway. Neuropsychopharmacology43:2028–35.
54.
IwakawaHOTomariY.2015. The functions of microRNAs: mRNA decay and translational repression. Trends Cell Biol25:651–65.
55.
JacksonRJHellenCUPestovaTV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol11:113–27.
56.
JamesCCSmythJW. 2018. Alternative mechanisms of translation initiation: an emerging dynamic regulator of the proteome in health and disease. Life Sci212:138–44.
57.
JamesMHQuinnRKOngLKLeviEMCharnleyJLSmithDW, and others. 2014. mTORC1 inhibition in the nucleus accumbens “protects” against the expression of drug seeking and “relapse” and is associated with reductions in GluA1 AMPAR and CAMKIIα levels. Neuropsychopharmacology39:1694–702.
58.
JamesMHQuinnRKOngLKLeviEMSmithDWDicksonPW, and others. 2016. Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum. Eur J Pharmacol784:147–54.
59.
JianMLuoYXXueYXHanYShiHSLiuJF, and others. 2014. eIF2α dephosphorylation in basolateral amygdala mediates reconsolidation of drug memory. J Neurosci34:10010–21.
60.
KarANLeeSJTwissJL. 2018. Expanding axonal transcriptome brings new functions for axonally synthesized proteins in health and disease. Neuroscientist24:111–29.
61.
KaraNZFlaisher-GrinbergSAndersonGWAgamGEinatH.2018. Mood-stabilizing effects of rapamycin and its analog temsirolimus: relevance to autophagy. Behav Pharmacol29:379–84.
62.
KaryoREskiraYPinhasovABelmakerRAgamGEldar-FinkelmanH.2010. Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3. Mol Cell Neurosci45:449–55.
63.
KimSHYuHSParkHGHaKKimYSShinSY, and others. 2013. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex. Prog Neuropsychopharmacol Biol Psychiatry45:73–82.
64.
KoobGFVolkowND. 2016. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry3:760–73.
65.
KumarVKimKJosephCKourrichSYooSHHuangHC, and others. 2013. C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science342:1508–12.
66.
LaguesseSMorisotNPhamluongKRonD.2017a. Region specific activation of the AKT and mTORC1 pathway in response to excessive alcohol intake in rodents. Addict Biol22:1856–69.
67.
LaguesseSMorisotNShinJHLiuFAdroverMFSakhaiSA, and others. 2017b. Prosapip1-dependent synaptic adaptations in the nucleus accumbens drive alcohol intake, seeking, and reward. Neuron96:145–59.e8.
68.
LapidusKANwokaforCScottDBaroniTETenenbaumSAHiroiN, and others. 2012. Transgenic expression of ZBP1 in neurons suppresses cocaine-associated conditioning. Learn Mem19:35–42.
69.
LeeYKimSGLeeBZhangYKimYKimS, and others. 2017. Striatal transcriptome and interactome analysis of Shank3-overexpressing mice reveals the connectivity between Shank3 and mTORC1 signaling. Front Mol Neurosci10:201.
70.
LeonenkoGRichardsALWaltersJTPocklingtonAChambertKAl EissaMM, and others. 2017. Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia. Am J Med Genet B Neuropsychiatr Genet174:724–31.
71.
LepetaKPurzyckaKJPachulska-WieczorekKMitjansMBegemannMVafadariB, and others 2017. A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms. EMBO Mol Med9:1100–16.
72.
LiNLeeBLiuRJBanasrMDwyerJMIwataM, and others. 2010. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science329:959–64.
73.
LiYJXuMGaoZHWangYQYueZZhangYX, and others. 2013. Alterations of serum levels of BDNF-related miRNAs in patients with depression. PLoS One8:e63648.
74.
LinJLiuLWenQZhengCGaoYPengS, and others. 2014. Rapamycin prevents drug seeking via disrupting reconsolidation of reward memory in rats. Int J Neuropsychopharmacology17:127–36.
75.
LiptonJOSahinM.2014. The neurology of mTOR. Neuron84:275–91.
LiuJStevensPDLiXSchmidtMDGaoT.2011. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Mol Cell Biol31:4917–27.
78.
LiuJJChiuYTDiMattioKMChenCHuangPGentileTA, and others. 2019. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in kappa opioid aversion. Neuropsychopharmacology44:939–49.
Machado-VieiraRZanettiMVTeixeiraALUnoMValiengoLLSoeiro-de-SouzaMG, and others. 2015. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder. Eur Neuropsychopharmacology25:468–73.
81.
MarcotrigianoJGingrasACSonenbergNBurleySK. 1999. Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol Cell3:707–16.
82.
Mazei-RobisonMSKooJWFriedmanAKLansinkCSRobisonAJVinishM, and others. 2011. Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron72:977–90.
83.
MeffreJChaumont-DubelSMannourylaCourCLoiseauFWatsonDJDekeyneA, and others. 2012. 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Mol Med4:1043–56.
84.
MeyersJLSallingMCAlmliLMRatanatharathornAUddinMGaleaS, and others. 2015. Frequency of alcohol consumption in humans; the role of metabotropic glutamate receptors and downstream signaling pathways. Transl Psychiatry5:e586.
85.
MeyuhasOKahanT.2015. The race to decipher the top secrets of TOP mRNAs. Biochim Biophys Acta1849:801–11.
86.
MigliaccioNMartucciNMRuggieroISangesCOhkuboSLambertiA, and others. 2016. Ser/Thr kinases and polyamines in the regulation of non-canonical functions of elongation factor 1A. Amino Acids48:2339–52.
87.
MonteggiaLMGideonsEKavalaliET. 2013. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine. Biol Psychiatry73:1199–203.
88.
MoonSLSonenbergNParkerR.2018. Neuronal regulation of eIF2α function in health and neurological disorders. Trends Mol Med24:575–89.
89.
MorisotNNovotnyCJShokatKMRonD.2018. A new generation of mTORC1 inhibitor attenuates alcohol intake and reward in mice. Addict Biol23:713–22.
NandagopalNRouxPP. 2015. Regulation of global and specific mRNA translation by the mTOR signaling pathway. Translation3:e983402.
92.
NaritaMAkaiHKitaTNagumoYNaritaMSunagawaN, and others. 2005. Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats. Neuroscience132:553–60.
93.
NeastaJBarakSHamidaSBRonD.2014. mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse. J Neurochem130:172–84.
94.
NeastaJBen HamidaSYowellQCarnicellaSRonD.2010. Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proc Natl Acad Sci U S A107:20093–8.
95.
NiereFNamjoshiSSongEDillyGASchoenhardGZemelmanBV, and others. 2016. Analysis of proteins that rapidly change upon mechanistic/mammalian target of rapamycin complex 1 (mTORC1) repression identifies Parkinson protein 7 (PARK7) as a novel protein aberrantly expressed in tuberous sclerosis complex (TSC). Mol Cell Proteomics15:426–44.
96.
O’DonovanMCCraddockNNortonNWilliamsHPeirceTMoskvinaV, and others. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet40:1053–5.
97.
OliverRJBrigmanJLBolognaniFAllanAMNeisewanderJLPerrone-BizzozeroNI. 2018. Neuronal RNA-binding protein HuD regulates addiction-related gene expression and behavior. Genes Brain Behav17:e12454.
98.
OtaKTAndresWLewisDAStockmeierCADumanRS. 2015. BICC1 expression is elevated in depressed subjects and contributes to depressive behavior in rodents. Neuropsychopharmacology40:711–8.
99.
PapadimaEMNiolaPMelisCPisanuCCongiuDCruceanuC, and others. 2017. Evidence towards RNA binding motif (RNP1, RRM) protein 3 (RBM3) as a potential biomarker of lithium response in bipolar disorder patients. J Mol Neurosci62:304–8.
100.
ParkEIaccarinoCLeeJKwonIBaikSMKimM, and others. 2011. Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA. J Biol Chem286:25301–8.
101.
Perrone-BizzozeroNBirdCW. 2013. Role of HuD in nervous system function and pathology. Front Biosci5:554–63.
102.
PetersonRTDesaiBNHardwickJSSchreiberSL. 1999. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Proc Natl Acad Sci U S A96:4438–42.
103.
PfaffensellerBWollenhaupt-AguiarBFriesGRColpoGDBurqueRKBristotG, and others. 2014. Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression. Int J Neuropsychopharmacology17:1453–63.
104.
PhamXSongGLaoSGoffLZhuHValleD, and others. 2016. The DPYSL2 gene connects mTOR and schizophrenia. Transl Psychiatry6:e933.
105.
PietrzykowskiAZFriesenRMMartinGEPuigSINowakCLWynnePM, and others. 2008. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron59:274–87.
106.
PlaczekANMolfeseDLKhatiwadaSVianaDiPriscoGHuangWSidrauskiC, and others. 2016a. Translational control of nicotine-evoked synaptic potentiation in mice and neuronal responses in human smokers by eIF2α. eLife5:e12056.
107.
PlaczekANPriscoGVKhatiwadaSSgrittaMHuangWKrnjevicK, and others. 2016b. eIF2α-mediated translational control regulates the persistence of cocaine-induced LTP in midbrain dopamine neurons. eLife5:e17517.
108.
ProudCG. 2015. Regulation and roles of elongation factor 2 kinase. Biochem Soc Trans43:328–32.
109.
PuighermanalEBusquets-GarciaAGomis-GonzalezMMarsicanoGMaldonadoROzaitaA.2013. Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology38:1334–43.
110.
PuighermanalEMarsicanoGBusquets-GarciaALutzBMaldonadoROzaitaA.2009. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci12:1152–8.
111.
QinXJiangBZhangY.2016. 4E-BP1, a multifactor regulated multifunctional protein. Cell Cycle15:781–6.
112.
QuinnRKJamesMHHawkinsGEBrownALHeathcoteASmithDW, and others. 2018. Temporally specific miRNA expression patterns in the dorsal and ventral striatum of addiction-prone rats. Addict Biol23:631–42.
113.
Raab-GrahamKFHaddickPCJanYNJanLY. 2006. Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science314:144–8.
114.
Raab-GrahamKFWorkmanERNamjoshiSNiereF.2016. Pushing the threshold: how NMDAR antagonists induce homeostasis through protein synthesis to remedy depression. Brain Res1647:94–104.
115.
RaimondeauEBuftonJCSchaffitzelC.2018. New insights into the interplay between the translation machinery and nonsense-mediated mRNA decay factors. Biochem Soc Trans46:503–12.
116.
RajkumarAPChristensenJHMattheisenMJacobsenIBacheIPallesenJ, and others. 2015. Analysis of t(9;17)(q33.2;q25.3) chromosomal breakpoint regions and genetic association reveals novel candidate genes for bipolar disorder. Bipolar Disord17:205–11.
117.
RavanidisSKattanFGDoxakisE.2018. Unraveling the pathways to neuronal homeostasis and disease: mechanistic insights into the role of RNA-binding proteins and associated factors. Int J Mol Sci19:E2280.
118.
RenardJLoureiroMRosenLGZunderJde OliveiraCSchmidS, and others. 2016. Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR/p70S6 kinase signaling pathway. J Neurosci36:5160–9.
SahooPKSmithDSPerrone-BizzozeroNTwissJL. 2018. Axonal mRNA transport and translation at a glance. J Cell Sci. 131:jcs196808.
121.
SalesAJFogacaMVSartimAGPereiraVSWegenerGGuimaraesFS, and others. 2019. Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex. Mol Neurobiol56:1070–81.
122.
SannaMDQuattroneAGaleottiN.2018. Antidepressant-like actions by silencing of neuronal ELAV-like RNA-binding proteins HuB and HuC in a model of depression in male mice. Neuropharmacology135:444–54.
123.
SantiniEHuynhTNKlannE.2014. Mechanisms of translation control underlying long-lasting synaptic plasticity and the consolidation of long-term memory. Prog Mol Biol Transl Sci122:131–67.
124.
SarkarAMarchettoMCGageFH. 2017. Synaptic activity: an emerging player in schizophrenia. Brain Res1656:68–75.
125.
SasabeTFutaiEIshiuraS.2011. Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D2. J Neurochem116:76–81.
126.
SaxtonRASabatiniDM. 2017. mTOR signaling in growth, metabolism, and disease. Cell169:361–71.
127.
SchullerAPGreenR.2018. Roadblocks and resolutions in eukaryotic translation. Nat Rev Mol Cell Biol19:526–41.
128.
ShahbazianDRouxPPMieuletVCohenMSRaughtBTauntonJ, and others. 2006. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J25:2781–91.
129.
ShiJJunWZhaoLYXueYXZhangXYKostenTR, and others. 2009. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts. Eur J Pharmacol615:108–12.
130.
SmalheiserNRLugliGRizaviHSTorvikVITureckiGDwivediY.2012. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One7:e33201.
131.
SmalheiserNRLugliGRizaviHSZhangHTorvikVIPandeyGN, and others. 2011. MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int J Neuropsychopharmacology14:1315–25.
SmithLNJedynakJPFontenotMRHaleCFDietzKCTaniguchiM, and others. 2014. Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration. Neuron82:645–58.
134.
SpencerKBMulhollandPJChandlerLJ. 2016. FMRP mediates chronic ethanol-induced changes in NMDA, Kv4.2, and KChIP3 expression in the hippocampus. Alcohol Clin Exp Res40:1251–61.
135.
SteinbergSGudmundsdottirSSveinbjornssonGSuvisaariJPaunioTTorniainen-HolmM, and others. 2017. Truncating mutations in RBM12 are associated with psychosis. Nat Genet49:1251–4.
136.
StewardOLevyWB. 1982. Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus. J Neurosci2:284–91.
137.
StollGPietilainenOPHLinderBSuvisaariJBrosiCHennahW, and others. 2013. Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nat Neurosci16:1228–37.
138.
SuttonLPCaronMG. 2015. Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine. Neuropharmacology99:610–9.
139.
TahaEGildishIGal-Ben-AriSRosenblumK.2013. The role of eEF2 pathway in learning and synaptic plasticity. Neurobiol Learn Mem105:100–6.
140.
TapocikJDBarbierEFlaniganMSolomonMPincusAPillingA, and others. 2014. microRNA-206 in rat medial prefrontal cortex regulates BDNF expression and alcohol drinking. J Neurosci34:4581–8.
141.
TavaresMRPavanICAmaralCLMeneguelloLLuchessiADSimabucoFM. 2015. The S6K protein family in health and disease. Life Sci131:1–10.
142.
ThoreenCCChantranupongLKeysHRWangTGrayNSSabatiniDM. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature485:109–13.
143.
TiruchinapalliDMCaronMGKeeneJD. 2008. Activity-dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain. J Neurochem107:1529–43.
144.
TopolAEnglishJAFlahertyERajarajanPHartleyBJGuptaS, and others. 2015. Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients. Transl Psychiatry5:e662.
145.
TorregrossaMMCorlettPRTaylorJR.2011. Aberrant learning and memory in addiction. Neurobiol Learn Mem96:609–23.
146.
TrinhMAKlannE.2013. Translational control by eIF2α kinases in long-lasting synaptic plasticity and long-term memory. Neurobiol Learn Mem105:93–9.
147.
Van DriescheSJMartinKC. 2018. New frontiers in RNA transport and local translation in neurons. Dev Neurobiol78:331–9.
148.
VoletiBNavarriaALiuRJBanasrMLiNTerwilligerR, and others. 2013. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry74:742–9.
149.
VoletiBTanisKQNewtonSSDumanRS. 2012. Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression. Biol Psychiatry71:51–8.
150.
VolkowNDKoobGFMcLellanAT. 2016. Neurobiologic advances from the brain disease model of addiction. N Engl J Med374:363–71.
151.
WangJXuWShaoJHeZDingZHuangJ, and others. 2017. miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats. Oncotarget8:28203–14.
152.
WangXLiWWilliamsMTeradaNAlessiDRProudCG. 2001. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 20:4370–9.
153.
WangXLuoYXHeYYLiFQShiHSXueLF, and others. 2010. Nucleus accumbens core mammalian target of rapamycin signaling pathway is critical for cue-induced reinstatement of cocaine seeking in rats. J Neurosci30:12632–41.
154.
WeissKAntoniouASchrattG.2015. Non-coding mechanisms of local mRNA translation in neuronal dendrites. Eur J Cell Biol94:363–7.
155.
WernerCTStefanikMTMilovanovicMCaccamiseAWolfME. 2018. Protein translation in the nucleus accumbens is dysregulated during cocaine withdrawal and required for expression of incubation of cocaine craving. J Neurosci38:2683–97.
156.
WolfeSAWorkmanERHeaneyCFNiereFNamjoshiSCacheauxLP, and others. 2016. FMRP regulates an ethanol-dependent shift in GABABR function and expression with rapid antidepressant properties. Nat Commun7:12867.
WorkmanERNiereFRaab-GrahamKF. 2018. Engaging homeostatic plasticity to treat depression. Mol Psychiatry23:26–35.
159.
WuJMcCallumSEGlickSDHuangY.2011. Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization. Neuroscience172:104–9.
160.
XuDSunYWangCWangHWangYZhaoW, and others. 2018. Hippocampal mTOR signaling is required for the antidepressant effects of paroxetine. Neuropharmacology128:181–95.
161.
XuYLiuHLiFSunNRenYLiuZ, and others. 2010. A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. J Affect Disord127:332–6.
162.
YerabhamASWeiergraberOHBradshawNJKorthC.2013. Revisiting disrupted-in-schizophrenia 1 as a scaffold protein. Biol Chem394:1425–37.
163.
YuCHDangYZhouZWuCZhaoFSachsMS, and others. 2015. Codon usage influences the local rate of translation elongation to regulate co-translational protein folding. Mol Cell59:744–54.
164.
YuJJZhangYWangYWenZYLiuXHQinJ, and others. 2013. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. Psychopharmacology225:361–72.
165.
ZhangBGuoFMaYSongYLinRShenFY, and others. 2017. Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD. Sci Rep7:3809.
166.
ZhouMLiWHuangSSongJKimJYTianX, and others. 2013. mTOR inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons. Neuron77:647–54.
167.
ZuckermanHPanZParkCBrietzkeEMusialNShariqAS, and others. 2018. Recognition and treatment of cognitive dysfunction in major depressive disorder. Front Psychiatry9:655.
